We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Why Should You Hold TransUnion Stock in Your Portfolio?
Read MoreHide Full Article
TransUnion (TRU - Free Report) is currently benefitting from a strong business model and strategic buyouts that are boosting the top line.
Shares of the company have gained 3% on a year-to-date basis compared with the industry’s rise of 2.3%.
With expected long-term earnings per share (EPS) growth rate of 8.1% and a market cap of $10.9 billion, it is a stock that investors should retain in their portfolios now.
Factors Driving TransUnion’s Performance
TransUnion’s successful acquisition strategy has played a vital role in its growth in the past five to six years. The strategy focuses on investment in unique and differentiated data assets, acquiring new capabilities for expanding in vertical markets and expanding international footprints.
So far in 2018, TransUnion has acquired Callcredit, iovation and Healthcare Payment Specialists. These buyouts are expected to help the company with new market entry and portfolio diversification, moving ahead. In October, the company inked a deal to purchase Rubixis, a healthcare revenue cycle solutions company.
This acquisition is expected to place TransUnion as a competitive player in the post-discharge revenue recovery market. Some notable buyouts of TransUnion in 2017 include DataLink services, FactorTrust and eBureau. All these acquisitions are contributing significantly to the top line.
TransUnion possesses an attractive business model with highly recurring and diverse revenue streams, significant operating leverage, low capital requirements as well as strong and stable cash flows. The inherent nature and significance of its solutions in customers’ decision-making endow it with high customer retention and revenue visibility.
A strong business model enables the company to serve a diverse range of customers across multiple geographies and verticals.
In spite of significant growth prospects, TransUnion is not free from headwinds. It has a debt-laden balance sheet that may limit expansion in the future and worsen its risk profile. Moreover, the company’s operating segments experiences seasonality that causes considerable fluctuations in revenues and profits. Nevertheless, we believe that strategic buyouts are likely to boost the company’s top line across all operating segments.
A few better-ranked stocks in the Zacks Business Services sector are BG Staffing, Inc. (BGSF - Free Report) , Booz Allen Hamilton Holding Corp. (BAH - Free Report) and The Interpublic Group of Companies, Inc. (IPG - Free Report) , each carrying a Zacks Rank #2 (Buy).
The long-term expected EPS (three to five years) growth rate for BG Staffing, Booz Allen and Interpublic is 20%, 14.4% and 7.6%, respectively.
3 Medical Stocks to Buy Now
The greatest discovery in this century of biology is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating revenue, and cures for a variety of deadly diseases are in the pipeline.
So are big potential profits for early investors. Zacks has released an updated Special Report that explains this breakthrough and names the best 3 stocks to ride it.
Image: Bigstock
Why Should You Hold TransUnion Stock in Your Portfolio?
TransUnion (TRU - Free Report) is currently benefitting from a strong business model and strategic buyouts that are boosting the top line.
Shares of the company have gained 3% on a year-to-date basis compared with the industry’s rise of 2.3%.
With expected long-term earnings per share (EPS) growth rate of 8.1% and a market cap of $10.9 billion, it is a stock that investors should retain in their portfolios now.
Factors Driving TransUnion’s Performance
TransUnion’s successful acquisition strategy has played a vital role in its growth in the past five to six years. The strategy focuses on investment in unique and differentiated data assets, acquiring new capabilities for expanding in vertical markets and expanding international footprints.
So far in 2018, TransUnion has acquired Callcredit, iovation and Healthcare Payment Specialists. These buyouts are expected to help the company with new market entry and portfolio diversification, moving ahead. In October, the company inked a deal to purchase Rubixis, a healthcare revenue cycle solutions company.
This acquisition is expected to place TransUnion as a competitive player in the post-discharge revenue recovery market. Some notable buyouts of TransUnion in 2017 include DataLink services, FactorTrust and eBureau. All these acquisitions are contributing significantly to the top line.
TransUnion possesses an attractive business model with highly recurring and diverse revenue streams, significant operating leverage, low capital requirements as well as strong and stable cash flows. The inherent nature and significance of its solutions in customers’ decision-making endow it with high customer retention and revenue visibility.
A strong business model enables the company to serve a diverse range of customers across multiple geographies and verticals.
TransUnion Price, Consensus and EPS Surprise
TransUnion Price, Consensus and EPS Surprise | TransUnion Quote
Wrapping Up
In spite of significant growth prospects, TransUnion is not free from headwinds. It has a debt-laden balance sheet that may limit expansion in the future and worsen its risk profile. Moreover, the company’s operating segments experiences seasonality that causes considerable fluctuations in revenues and profits. Nevertheless, we believe that strategic buyouts are likely to boost the company’s top line across all operating segments.
Zacks Rank & Stocks to Consider
Currently, TransUnion carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
A few better-ranked stocks in the Zacks Business Services sector are BG Staffing, Inc. (BGSF - Free Report) , Booz Allen Hamilton Holding Corp. (BAH - Free Report) and The Interpublic Group of Companies, Inc. (IPG - Free Report) , each carrying a Zacks Rank #2 (Buy).
The long-term expected EPS (three to five years) growth rate for BG Staffing, Booz Allen and Interpublic is 20%, 14.4% and 7.6%, respectively.
3 Medical Stocks to Buy Now
The greatest discovery in this century of biology is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating revenue, and cures for a variety of deadly diseases are in the pipeline.
So are big potential profits for early investors. Zacks has released an updated Special Report that explains this breakthrough and names the best 3 stocks to ride it.
See them today for free >>